Nipro (TSE:8086) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:8086 Nipro Corp TSE:8086
70 GF Score
Price 円1,552.50
GF Value 円1,457.04
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Nipro Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


TSE:8086 vs ISRG, BDX, MDLN: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Short Interest distribution charts can be found below:

* The bar in red indicates where Nipro's Short Interest falls into.


TSE:8086
70GF Score
Nipro Corp TSE:8086
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nipro (TSE:8086) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be overvalued. The current stock price of 円1,552.50 is trading 6.6% above its estimated GF Value™ of 円1,457.04. GuruFocus considers Nipro to be Fairly Valued.

Key valuation signals for TSE:8086:

  • Short Interest:
  • GF Value™: 円1,457.04 vs. price of 円1,552.50 (6.6% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 5FA:Germany
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
70GF Score

Get the complete analysis for TSE:8086

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,552.50
Price
円1,457.04
GF Value